Biomm (BSP:BIOM3) Short-Term Debt: R$72.5 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BIOM3 Biomm SA BSP:BIOM3
49 GF Score
Price R$6.34
GF Value R$18.87
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Biomm Short-Term Debt?

Biomm BSP:BIOM3 -0.31% 49 Short-Term Debt is R$72.5 Mil as of Jun. 2026. GuruFocus rates BSP:BIOM3 with a GF Score™ of 49/100 and a GF Value™ of R$18.87 (Possible Value Trap). The stock has 4 warning signs investors should review.

Biomm's Short-Term Debt for the quarter that ended in Jun. 2026 was R$72.5 Mil.

Biomm's quarterly Short-Term Debt increased from Dec. 2025 (R$45.7 Mil) to Mar. 2026 (R$54.1 Mil) and increased from Mar. 2026 (R$54.1 Mil) to Jun. 2026 (R$72.5 Mil).

Biomm's annual Short-Term Debt declined from Dec. 2023 (R$47.7 Mil) to Dec. 2024 (R$44.5 Mil) but then increased from Dec. 2024 (R$44.5 Mil) to Dec. 2025 (R$45.7 Mil).

Biomm Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biomm Short-Term Debt Related Terms

Biomm Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Biomm's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomm Short-Term Debt Chart

Biomm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.08 51.06 47.66 44.50 45.69

Biomm Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.18 38.64 45.69 54.11 72.52
BSP:BIOM3
49GF Score
Biomm SA BSP:BIOM3
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of R$72.5 Mil mean?
Biomm (BSP:BIOM3) has a Short-Term Debt of R$72.5 Mil as of Jun. 2026.
Is Biomm's Short-Term Debt too high?
Biomm's current Short-Term Debt is R$72.5 Mil. Overall, Biomm has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biomm's Short-Term Debt compare to VRTX and REGN?
Biomm's Short-Term Debt of R$72.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Biomm's current Short-Term Debt is R$72.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomm stock overvalued right now?
Based on GuruFocus' analysis, Biomm (BSP:BIOM3) is currently considered Possible Value Trap. The stock's GF Value™ is R$18.87, compared to a current price of R$6.34 — trading 66.4% below its estimated fair value. The current Short-Term Debt is R$72.5 Mil. Biomm's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Biomm (BSP:BIOM3), the current Short-Term Debt is R$72.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biomm (BSP:BIOM3) Overvalued in 2026?

Based on GuruFocus' analysis, Biomm stock appears to be undervalued. The current stock price of R$6.34 is trading 66.4% below its estimated GF Value™ of R$18.87. GuruFocus considers Biomm to be Possible Value Trap.

Key valuation signals for BSP:BIOM3:

  • Short-Term Debt: R$72.5 Mil
  • GF Value™: R$18.87 vs. price of R$6.34 (66.4% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the BSP:BIOM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biomm Business Description

Address Praca Carlos Chagas 49 - 8th Floor, Belo Horizonte, Minas Gerais, MG, BRA, 30170020
Biomm SA is engaged in biotechnological processes for the production of active pharmaceutical ingredients and other industrial purposes, such as enzymes used in the production of Biofuels.The Company is patented for insulin production.The company develops processes for the production of insulin and other biotech products, as well as processes for other industrial applications, such as enzymes that are used in the production of biofuels.
49GF Score

Get the complete analysis for BSP:BIOM3

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.34
Price
R$18.87
GF Value